Predictors of hemoglobin decline in non-metastatic prostate cancer patients on androgen deprivation therapy: a matched cohort study

被引：0
|
作者：
Narhari Timilshina
Shabbir Hussain
Henriette Breunis
Shabbir M. H. Alibhai
机构：
[1] University Health Network,Division of General Internal Medicine & Clinical Epidemiology
[2] Toronto Rehabilitation Institute,Geriatric Program
[3] University of Toronto,Department of Medicine
[4] University of Toronto,Department of Health Policy, Management and Evaluation
来源：
Supportive Care in Cancer | 2011年 / 19卷
关键词：
Anemia; Prostate cancer; Androgen deprivation therapy; Aged;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1815 / 1821
页数：6
相关论文
共 50 条
  • [21] Editorial on an international survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
    Sternberg, Cora N.
    ESMO OPEN, 2016, 1 (02)
  • [22] ASSOCIATION BETWEEN ANDROGEN-DEPRIVATION THERAPY AND NON-PROSTATE CANCER MORTALITY AMONG MEN WITH NON-METASTATIC PROSTATE CANCER
    Wallis, Christopher
    Satkunasivam, Raj
    Herschorn, Sender
    Law, Calvin
    Seth, Arun
    Kodama, Ronald
    Kulkarni, Girish
    Nam, Robert
    JOURNAL OF UROLOGY, 2018, 199 (04): : E274 - E275
  • [23] Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer
    Cherrier, M. M.
    Cross, D. J.
    Higano, C. S.
    Minoshima, S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (03) : 394 - 402
  • [24] Predictors of Clinical Metastases and Survival among Non-Metastatic Prostate Cancer (PC) Patients (pts) Treated with Androgen-Deprivation Therapy (ADT) in Sweden
    Hernandez, Rohini K.
    Mesterton, Johan
    Banefelt, Jonas
    Stalhammar, Jan
    Sobocki, Patrik
    Persson, Bo-Eric
    Liede, Alexander
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 6 - 6
  • [25] Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer
    M. M. Cherrier
    D. J. Cross
    C. S. Higano
    S. Minoshima
    Prostate Cancer and Prostatic Diseases, 2018, 21 : 394 - 402
  • [26] The role of androgen deprivation therapy plus radiation therapy in patients with non-metastatic prostate cancer (vol 16, pg 929, 2016)
    Zhao, S.
    Urdaneta, A., I
    Anscher, M. S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (12) : 1323 - 1323
  • [27] Cost effectiveness of adding bisphosphonates to the non-surgical androgen deprivation therapy for fracture reduction in patients with non-metastatic prostate cancer
    Phatak, HM
    Thomas, J
    VALUE IN HEALTH, 2004, 7 (03) : 248 - 248
  • [28] Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer
    Iwamoto, Hiroaki
    Kano, Hiroshi
    Shimada, Takafumi
    Naito, Renato
    Makino, Tomoyuki
    Kadamoto, Suguru
    Yaegashi, Hiroshi
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Kadonoa, Yoshifumi
    Mizokami, Atsushi
    IN VIVO, 2021, 35 (02): : 1247 - 1252
  • [29] Real-world outcome data from patients with non-metastatic prostate cancer treated with primary androgen deprivation therapy
    Palmer, K.
    Patel, K.
    Ghose, A.
    Killen, H.
    Wells, P.
    Tipples, K.
    CLINICAL ONCOLOGY, 2025, 38
  • [30] Men with poor-prognosis non-metastatic prostate cancer can be cured with adjuvant androgen deprivation therapy
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 288 - 288
12345